The global molecular biology enzymes, kits, and reagents market is on the brink of significant expansion, with projections indicating a remarkable increase in value to USD 48,476.41 million by 2032.
This is an important piece of work that sheds light on our understanding of early lung development. There is solid evidence that there is a key new role for Svep1, which may be acting via FGF9. A more ...